Q2 2026 Holdings
Filed 2026-08-14 | 68 holdings | $2.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Erasca Inc(ERAS) | COM | 29479A108 | $222.6M | 12,150,000 | 9.6% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $136.5M | 1,024,000 | 5.9% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $131.1M | 700,000 | 5.6% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $111.8M | 3,000,000 | 4.8% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $94.4M | 1,015,000 | 4.1% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $94.4M | 2,200,000 | 4.1% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $89.1M | 2,850,000 | 3.8% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $87.0M | 260,000 | 3.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $78.1M | 2,100,000 | 3.4% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $78.0M | 800,000 | 3.4% |
| CG Oncology Inc(CGON) | COM | 156944100 | $71.1M | 1,000,000 | 3.1% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $64.0M | 875,000 | 2.8% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $57.7M | 1,935,000 | 2.5% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $56.6M | 2,550,000 | 2.4% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $52.1M | 2,675,000 | 2.2% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $52.0M | 5,300,000 | 2.2% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $43.4M | 3,000,000 | 1.9% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $40.1M | 3,208,875 | 1.7% |
| Belite BIO Inc(BLTE) | SPONSORED ADS | 07782B104 | $38.5M | 250,000 | 1.7% |
| Achieve Life Science Inc(ACHV) | COM | 004468500 | $35.4M | 5,425,000 | 1.5% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $35.1M | 1,880,000 | 1.5% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $34.8M | 900,000 | 1.5% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $34.7M | 1,000,000 | 1.5% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $34.2M | 1,900,000 | 1.5% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $31.8M | 2,250,000 | 1.4% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $28.3M | 1,050,000 | 1.2% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $27.7M | 2,500,000 | 1.2% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $27.2M | 450,000 | 1.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $26.8M | 500,000 | 1.2% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $25.6M | 665,000 | 1.1% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $25.0M | 1,125,000 | 1.1% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $23.6M | 465,000 | 1.0% |
| Veradermics Inc(MANE) | COMMON STOCK | 922967104 | $22.1M | 180,000 | 1.0% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $21.3M | 1,150,000 | 0.9% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $20.0M | 650,000 | 0.9% |
| Summit Therapeutics Inc(SMMT) | COM | 86627T108 | $19.7M | 1,350,000 | 0.8% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $19.1M | 600,000 | 0.8% |
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $19.0M | 585,000 | 0.8% |
| Minerva Neurosciences Inc(NERV) | COM NEW | 603380205 | $18.3M | 3,288,777 | 0.8% |
| Faeth Therapeutics Inc(SNSE) | COM NEW | 81728A207 | $18.1M | 722,020 | 0.8% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $16.4M | 300,000 | 0.7% |
| DBV Technologies S A(DBVT) | SPONSORED ADS | 23306J309 | $15.0M | 915,000 | 0.6% |
| Parabilis Medicines Inc(PBLS) | COM | 698955101 | $14.4M | 525,000 | 0.6% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $13.9M | 125,000 | 0.6% |
| VOR Biopharma Inc(VOR) | COM NEW | 929033207 | $12.0M | 650,000 | 0.5% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $11.0M | 200,000 | 0.5% |
| Immix Biopharma Inc(IMMX) | COM | 45258H106 | $10.3M | 1,000,000 | 0.4% |
| Q32 BIO Inc(QTTB) | COM | 746964105 | $10.2M | 800,000 | 0.4% |
| Odyssey Therapeutics Inc(ODTX) | COMMON STOCK | 67613T104 | $9.8M | 521,736 | 0.4% |
| Annexon Inc(ANNX) | COM | 03589W102 | $8.6M | 1,500,000 | 0.4% |